Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates
Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates

Fidelity National Financial (FNF) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year

Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates
Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates

Drilling Tools International Corp. (DTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.14

IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates
IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates

IREN Limited (IREN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are adjusted

Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note

Veeva Systems (VEEV) ended the recent trading session at $291.21, demonstrating a -1.37% change from the preceding day's closing price. This change lagged the S&P 500's 1.12% loss on the day

AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates
AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates

AerSale Corporation (ASLE) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago. These

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.17 per share a year ago. These

Nutanix (NTNX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Nutanix (NTNX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Nutanix (NTNX) ended the recent trading session at $68.80, demonstrating a -1.31% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of

Sea Limited Sponsored ADR (SE) Declines More Than Market: Some Information for Investors
Sea Limited Sponsored ADR (SE) Declines More Than Market: Some Information for Investors

Sea Limited Sponsored ADR (SE) ended the recent trading session at $153.56, demonstrating a -2.66% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 1.12%

DiamondRock Hospitality (DRH) Surpasses Q3 FFO and Revenue Estimates
DiamondRock Hospitality (DRH) Surpasses Q3 FFO and Revenue Estimates

DiamondRock Hospitality (DRH) came out with quarterly funds from operations (FFO) of $0.29 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to FFO of $0.26 per share

Why Ulta Beauty (ULTA) Dipped More Than Broader Market Today
Why Ulta Beauty (ULTA) Dipped More Than Broader Market Today

Ulta Beauty (ULTA) ended the recent trading session at $510.06, demonstrating a -2.25% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.12%. Elsewhere

Here's Why Adobe Systems (ADBE) Fell More Than Broader Market
Here's Why Adobe Systems (ADBE) Fell More Than Broader Market

Adobe Systems (ADBE) ended the recent trading session at $327.35, demonstrating a -2.44% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of

Sweetgreen, Inc. (SG) Reports Q3 Loss, Lags Revenue Estimates
Sweetgreen, Inc. (SG) Reports Q3 Loss, Lags Revenue Estimates

Sweetgreen, Inc. (SG) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.18 per share a year ago. These figures

The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates

The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago

Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.25 per share a year ago. These

MP Materials Corp. (MP) Reports Q3 Loss, Tops Revenue Estimates
MP Materials Corp. (MP) Reports Q3 Loss, Tops Revenue Estimates

MP Materials Corp. (MP) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.12 per share a year ago. These figures

Onto Innovation (ONTO) Tops Q3 Earnings Estimates
Onto Innovation (ONTO) Tops Q3 Earnings Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1.34 per share a year ago. These

PAR Technology (PAR) Misses Q3 Earnings Estimates
PAR Technology (PAR) Misses Q3 Earnings Estimates

PAR Technology (PAR) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.09 per share a year ago. These

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.53 per share a year ago. These

Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates
Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates

Huntsman (HUN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.1 per share a year ago. These figures are

Figs (FIGS) Beats Q3 Earnings and Revenue Estimates
Figs (FIGS) Beats Q3 Earnings and Revenue Estimates

Figs (FIGS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.01 per share a year ago. These figures are

Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates

Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.39 per share a year ago. These figures

Universal Logistics (ULH) Beats Q3 Earnings Estimates
Universal Logistics (ULH) Beats Q3 Earnings Estimates

Universal Logistics (ULH) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $1.01 per share a year ago. These

Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates
Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates

Five9 (FIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.67 per share a year ago. These figures are

Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates
Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates

Microchip Technology (MCHP) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.46 per share a year ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.13. This compares to earnings of $0.02 per share a year ago. These